Gp Act Iii Acquisition Stock Price To Earning
| GPAT Stock | 10.49 0.03 0.29% |
GP Act's fundamental analysis aims to assess its intrinsic value by examining key economic and financial indicators - such as cash flow records, changes in balance sheet accounts, income statement trends, financial ratios, and relevant microeconomic factors affecting GPAT Stock price.
GPAT | Price To Earning | Build AI portfolio with GPAT Stock |
GP Act III Acquisition Company Price To Earning Analysis
GP Act's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
GPAT Price To Earning Driver Correlations
Understanding the fundamental principles of building solid financial models for GP Act is extremely important. It helps to project a fair market value of GPAT Stock properly, considering its historical fundamentals such as Price To Earning. Since GP Act's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of GP Act's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of GP Act's interrelated accounts and indicators.
Click cells to compare fundamentals
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
GPAT Retained Earnings
Retained Earnings |
|
Based on the latest financial disclosure, GP Act III Acquisition has a Price To Earning of 0.0 times. This is 100.0% lower than that of the Financial Services sector and 100.0% lower than that of the Financials industry. The price to earning for all United States stocks is 100.0% higher than that of the company.
GPAT Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GP Act's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of GP Act could also be used in its relative valuation, which is a method of valuing GP Act by comparing valuation metrics of similar companies.GP Act is currently under evaluation in price to earning category among its peers.
GP Act ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, GP Act's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to GP Act's managers, analysts, and investors.Environmental | Governance | Social |
GPAT Fundamentals
| Return On Asset | -0.0029 | ||||
| Current Valuation | 376.9 M | ||||
| Shares Outstanding | 28.75 M | ||||
| Shares Owned By Institutions | 96.48 % | ||||
| Number Of Shares Shorted | 1.84 K | ||||
| Price To Book | 1.33 X | ||||
| EBITDA | 8.67 M | ||||
| Net Income | 8.67 M | ||||
| Total Debt | 400 K | ||||
| Book Value Per Share | (1.97) X | ||||
| Cash Flow From Operations | (584.72 K) | ||||
| Short Ratio | 0.02 X | ||||
| Earnings Per Share | 0.34 X | ||||
| Market Capitalization | 376.98 M | ||||
| Total Asset | 297.47 M | ||||
| Retained Earnings | (13.93 M) | ||||
| Working Capital | 43.75 K | ||||
| Net Asset | 297.47 M |
About GP Act Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GP Act III Acquisition's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GP Act using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GP Act III Acquisition based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for GPAT Stock Analysis
When running GP Act's price analysis, check to measure GP Act's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GP Act is operating at the current time. Most of GP Act's value examination focuses on studying past and present price action to predict the probability of GP Act's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GP Act's price. Additionally, you may evaluate how the addition of GP Act to your portfolios can decrease your overall portfolio volatility.